Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Karl Deres"'
Publikováno v:
Journal of Virology. 78:13812-13818
The carboxy-terminal sequence of the hepatitis B virus (HBV) core protein constitutes a nucleic acid binding domain that is rich in arginine residues and contains three serine phosphorylation sites. While dispensable for capsid assembly, this domain
Autor:
Stanley G. Nathenson, Ton N. Schumacher, Hidde L. Ploegh, Grada M. van Bleek, Mónica Imarai, Marie Therese Heemels, Ka Wan Li, Karl Deres, L.N. Vernie
Publikováno v:
European Journal of Immunology. 22:1405-1412
Major histocompatibility complex (MHC) class I molecules combine with short peptides of defined length and sequence. Here we describe an approach that may be used in the analysis of peptide preference of different allelic MHC class I molecules, and i
Publikováno v:
Biochemical pharmacology. 66(12)
Recently, heteroarylpyrimidines (HAP) have been identified as potent inhibitors of capsid maturation. Here we discuss the HAP mode of action comparing the aggregation phenotype of wild-type and mutant core proteins with the respective phenotype impos
Publikováno v:
Viral Infections and Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecd892e499af1b5a2dcd7f0b140cd19a
https://doi.org/10.1201/b14823
https://doi.org/10.1201/b14823
Autor:
Hans Jörg Hacker, Karl-Heinz Schlemmer, Thomas Krämer, Ralf N. A. Masantschek, Ulrich Niewöhner, Jurgen D I Stoltefuss, Ruebsamen-Waigmann Helga, Arnold Paessens, Dieter Haebich, Anja Reimann, Erwin Graef, Diana Koletzki, Rainer Gros, Claus H. Schröder, Bernhard Beckermann, Olaf Weber, Siegfried Goldmann, Ulrich Pleiss, Karl Deres, Rainer Jaeger
Publikováno v:
Science (New York, N.Y.). 299(5608)
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-α and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy. However, these therapies are limited by the side effec
Autor:
Dieter Haebich, Olaf Weber, E. Hartmann, Helga Prof Ruebsamen-Waigmann, Arnold Dr. Paessens, U. Niewoehner, Graef Erwin, Jürgen Dr. Stoltefuss, Ina Hagelschuer, Karl Deres, S. Goldmann, K.-H. Schlemmer, Stefan Dr Wohlfeil
Publikováno v:
Antiviral research. 54(2)
BAY 41-4109 is a member of a class of heteroaryl-pyrimidines that was recently identified as potent inhibitors of human hepatitis B virus (HBV) replication. We have investigated the antiviral activity of BAY 41-4109 (methyl (R)-4-(2-chloro-4-fluoroph
Autor:
Jörg W. Metzger, Hansjörg Schild, Karl Deres, Günther Jung, Kirsten Falk, Maria Norda, Hans-Georg Rammensee, Olaf Rötzschke
Publikováno v:
Nature. 348:252-254
Virus-infected cells can be eliminated by cytotoxic T lymphocytes (CTL), which recognize virus-derived peptides bound to major histocompatibility complex (MHC) class I molecules on the cell surface. Until now, this notion has relied on overwhelming b
Publikováno v:
European journal of immunology. 28(3)
Ceramide generated by lysosomal acid sphingomyelinase (aSMase) has been proposed to contribute to CD28 co-stimulatory signaling pathways. We used an aSMase-deficient mouse line ( asmase − / − ) to elucidate the role of the aSMase in splenocytes s
Autor:
Manuel Loleit, Marianne Eckert, Karl-Heinz Wiesmüller, Karl Deres, Wolfgang G. Bessler, Günther Jung
Publikováno v:
Biological chemistry Hoppe-Seyler. 375(6)
The lipoprotein (LP) from Escherichia coli and other Enterobacteriaceae as well as lipoprotein derived lipopeptides constitute potent B lymphocyte mitogens. Several synthetic peptide segments of the lipoprotein were tested for mitogenic activity towa
Publikováno v:
Cellular immunology. 151(1)
MHC class I molecules present octa- or nonapeptides derived from cellular proteins. Such peptides adhere to strict rules, which are individual to each MHC allele. Synthetic peptides conforming to these rules or peptides being at variance at critical